Tilia Fiduciary Partners Inc. Raises Stake in The Procter & Gamble Company (NYSE:PG)

Tilia Fiduciary Partners Inc. boosted its position in The Procter & Gamble Company (NYSE:PG) by 3.3% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,262 shares of the company’s stock after buying an additional 73 shares during the quarter. Tilia Fiduciary Partners Inc.’s holdings in Procter & Gamble were worth $392,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also bought and sold shares of PG. Itau Unibanco Holding S.A. bought a new stake in Procter & Gamble in the second quarter valued at approximately $28,000. Fairway Wealth LLC bought a new position in shares of Procter & Gamble during the second quarter valued at approximately $29,000. Ruedi Wealth Management Inc. boosted its position in shares of Procter & Gamble by 64.7% in the 1st quarter. Ruedi Wealth Management Inc. now owns 196 shares of the company’s stock worth $32,000 after purchasing an additional 77 shares in the last quarter. POM Investment Strategies LLC purchased a new stake in shares of Procter & Gamble in the 2nd quarter worth approximately $34,000. Finally, Transcendent Capital Group LLC bought a new position in Procter & Gamble during the 4th quarter valued at approximately $31,000. Hedge funds and other institutional investors own 65.77% of the company’s stock.

Insider Transactions at Procter & Gamble

In other news, CEO Jon R. Moeller sold 7,007 shares of the stock in a transaction that occurred on Wednesday, October 2nd. The shares were sold at an average price of $171.65, for a total value of $1,202,751.55. Following the completion of the sale, the chief executive officer now owns 269,172 shares of the company’s stock, valued at $46,203,373.80. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. In other news, CEO Jon R. Moeller sold 7,007 shares of the firm’s stock in a transaction on Wednesday, October 2nd. The shares were sold at an average price of $171.65, for a total value of $1,202,751.55. Following the sale, the chief executive officer now directly owns 269,172 shares in the company, valued at approximately $46,203,373.80. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Susan Street Whaley sold 634 shares of the stock in a transaction on Wednesday, October 2nd. The shares were sold at an average price of $171.65, for a total transaction of $108,826.10. Following the completion of the transaction, the insider now directly owns 19,341 shares in the company, valued at $3,319,882.65. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 383,194 shares of company stock valued at $65,140,718 over the last 90 days. Corporate insiders own 0.17% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages recently weighed in on PG. Dbs Bank downgraded shares of Procter & Gamble from a “strong-buy” rating to a “hold” rating in a research report on Thursday, August 1st. JPMorgan Chase & Co. increased their price target on Procter & Gamble from $179.00 to $186.00 and gave the company an “overweight” rating in a report on Thursday, September 19th. Evercore ISI increased their target price on Procter & Gamble from $177.00 to $183.00 and gave the company an “outperform” rating in a report on Thursday, July 18th. DZ Bank raised Procter & Gamble from a “hold” rating to a “buy” rating and set a $190.00 target price on the stock in a research report on Thursday, August 29th. Finally, TD Cowen started coverage on shares of Procter & Gamble in a research note on Tuesday, July 23rd. They issued a “buy” rating and a $189.00 price objective on the stock. Nine research analysts have rated the stock with a hold rating, twelve have assigned a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $175.89.

Procter & Gamble Stock Performance

Shares of PG traded up $0.72 during trading hours on Wednesday, reaching $168.88. 3,090,514 shares of the company traded hands, compared to its average volume of 6,653,880. The stock has a market capitalization of $398.58 billion, a P/E ratio of 27.48, a P/E/G ratio of 3.73 and a beta of 0.41. The company has a quick ratio of 0.53, a current ratio of 0.73 and a debt-to-equity ratio of 0.51. The Procter & Gamble Company has a 12-month low of $141.66 and a 12-month high of $177.94. The business has a fifty day moving average price of $171.22 and a 200-day moving average price of $166.63.

Procter & Gamble (NYSE:PG) last posted its earnings results on Tuesday, July 30th. The company reported $1.40 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.37 by $0.03. The company had revenue of $20.53 billion during the quarter, compared to the consensus estimate of $20.69 billion. Procter & Gamble had a net margin of 17.71% and a return on equity of 33.46%. The firm’s quarterly revenue was down .1% on a year-over-year basis. During the same period in the previous year, the firm posted $1.37 earnings per share. Equities analysts anticipate that The Procter & Gamble Company will post 6.97 EPS for the current fiscal year.

Procter & Gamble Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be paid a dividend of $1.0065 per share. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.38%. Procter & Gamble’s dividend payout ratio is currently 65.69%.

Procter & Gamble Profile

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.